Author: Nam Jong H Alnoah Zaid Yenumula Sudha R Murthy Sreekant
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.13, Iss.8, 2003-08, pp. : 1213-1267
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rifaximin for the treatment of irritable bowel syndrome
By Cremonini Filippo Lembo Anthony
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. :
Treatment Options for Irritable Bowel Syndrome Set to Increase
Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 1, 2004-05 ,pp. :